Yu Liu , Gefei He , Jianye Yan , Meimin Pan , Binqing Qu
{"title":"Pharmacokinetics of Matrine in blood and prostate tissue: a microdialysis-HPLC study in a rabbit model","authors":"Yu Liu , Gefei He , Jianye Yan , Meimin Pan , Binqing Qu","doi":"10.1016/j.phyplu.2025.100801","DOIUrl":null,"url":null,"abstract":"<div><div>KangFuXiaoYan suppository exhibits therapeutic potential for chronic prostatitis (CP) ,however, its in vivo pharmacokinetic process remains to be elucidated. This study investigated the pharmacokinetics of Matrine, the primary bioactive component of KangFuXiaoYan suppository, using high-performance liquid chromatography (HPLC) with microdialysis in rabbits. The results showed that the C<sub>max</sub> of Matrine in jugular vein and prostate tissue were (86.92 ± 2.66) and (45.33 ± 3.65) mg L<sup>-1</sup>,the T<sub>max</sub> were (30 ± 0.00) and (45 ± 0.00) min, the T<sub>1/2</sub> were (23.55 ± 1.76) and (26.50 ± 5.57) min, the AUC<sub>0-t</sub> were (4192.77 ± 67.85) and (2919.78 ± 40.17) mg min L<sup>-1</sup>,the MRT<sub>0-t</sub> were (48.90 ± 0.13)and (56.25 ± 1 .06) min. Matrine absorption, distribution, and penetration into prostate tissue were quantified. The results demonstrated rapid absorption into blood and prostate tissue, achieving a penetration rate of 73 %, suggesting potential therapeutic effectiveness for chronic prostatitis treatment. These findings provided experimental support for the clinical application of rectally administered KangFuXiaoYan suppository.</div></div>","PeriodicalId":34599,"journal":{"name":"Phytomedicine Plus","volume":"5 2","pages":"Article 100801"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytomedicine Plus","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667031325000739","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
KangFuXiaoYan suppository exhibits therapeutic potential for chronic prostatitis (CP) ,however, its in vivo pharmacokinetic process remains to be elucidated. This study investigated the pharmacokinetics of Matrine, the primary bioactive component of KangFuXiaoYan suppository, using high-performance liquid chromatography (HPLC) with microdialysis in rabbits. The results showed that the Cmax of Matrine in jugular vein and prostate tissue were (86.92 ± 2.66) and (45.33 ± 3.65) mg L-1,the Tmax were (30 ± 0.00) and (45 ± 0.00) min, the T1/2 were (23.55 ± 1.76) and (26.50 ± 5.57) min, the AUC0-t were (4192.77 ± 67.85) and (2919.78 ± 40.17) mg min L-1,the MRT0-t were (48.90 ± 0.13)and (56.25 ± 1 .06) min. Matrine absorption, distribution, and penetration into prostate tissue were quantified. The results demonstrated rapid absorption into blood and prostate tissue, achieving a penetration rate of 73 %, suggesting potential therapeutic effectiveness for chronic prostatitis treatment. These findings provided experimental support for the clinical application of rectally administered KangFuXiaoYan suppository.